DCFBC F-18

DB14772InvestigationalSmall molecule

DCFBC F-18 is under investigation in clinical trial NCT02190279 (18F-DCFBC PET/CT in Prostate Cancer).

Mechanism: Pharmacologically active on Glutamate carboxypeptidase 2
Curator reviewed
Formula / weight: C₁₆H₁₉FN₂O₇S · 401.4 g/mol (avg)
Also known as: 18F DCFBC

Resolves to

Compound

Structure

InChIKeyIDTMSHGCAZPVLC-STUNTBJNSA-NSMILESOC(=O)CC[C@H](NC(=O)N[C@@H](CSCC1=CC=C([18F])C=C1)C(O)=O)C(O)=O

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with DCFBC F-18, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.